J2U-18671-98221
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 787 / TX
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-17
Registered in v-safe
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Ear pain, Pain in jaw — Feeling: Fair · Joint pains, Muscle or body achesFree text: Ear jaw painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
- 2021-03-23
- 2021-03-30
- 2021-04-13
- 2021-04-22
- 2021-04-27
- 2021-06-15
- 2021-09-14
-
2021-10-29
Dose 2 — Janssen/Johnson & Johnson
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-04
- 2021-11-07
- 2021-11-12
- 2021-11-19
- 2021-11-28
- 2021-12-03
- 2021-12-10
- 2022-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-29 | Janssen/Johnson & Johnson | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Ear jaw pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Ear pain | ✓ | ✓ | ✓ |
| SRO | Pain in jaw | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release